Krystal Biotech, Inc. KRYS PEG ratio
PEG ratio at other companies
Other financials
Where this comes from
Calculated from Krystal Biotech, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s peg ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s PEG ratio?
- Krystal Biotech, Inc. (KRYS) reported PEG ratio of 0.4× in Q1 2026.
- How has Krystal Biotech, Inc.'s PEG ratio changed year-over-year?
- Krystal Biotech, Inc.'s PEG ratio increased by 14.8% year-over-year, from 0.4× to 0.4×.
- What does PEG ratio mean?
- The P/E ratio adjusted for how fast earnings are growing.
- How do you interpret PEG ratio?
- Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
- How does PEG ratio compare across companies?
- A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.